XML 81 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Other Intangible Assets
6 Months Ended
Jan. 31, 2014
Goodwill and Other Intangible Assets

7. Goodwill and Other Intangible Assets

Goodwill

The carrying value of our goodwill at January 31, 2014 and July 31, 2013 was $57.0 million and $50.1 million, respectively. The difference between the two periods relates to goodwill associated with the acquisition of PocketSonics of $6.9 million. We recorded a goodwill asset of $2.8 million, representing the value of the opportunity of further strengthening our competitive position. The goodwill associated with the acquisition was increased by an additional $4.1 million for the deferred tax liability on the IPR&D. Please refer to Note 3. Business Combinations for more information on the acquisition of PocketSonics.

Other intangible assets

Other intangible assets include the value assigned to intellectual property and other technology, patents, customer contracts and relationships, tradenames, and IPR&D. Except for IPR&D and one tradename asset, which are considered to have indefinite lives, all intangible assets have estimated useful lives of between 1 and 14 years.

Other intangible assets are summarized as follows:

 

     As of January 31, 2014      As of July 31, 2013  
(in millions)        Cost          Accumulated
Amortization
     Net      Cost      Accumulated
Amortization
     Net  

Developed technologies

   $ 18.1       $ 7.7       $ 10.4       $ 18.1       $ 6.6       $ 11.5   

Customer relationships

     43.9         12.7         31.2         43.9         10.2         33.7   

Backlog

     2.1         2.1         -         2.1         2.1         -   

Tradenames

     8.5         0.3         8.2         8.5         0.1         8.4   

In-process research and development

     11.5         -         11.5         1.9         -         1.9   

Total intangible assets

   $ 84.1       $ 22.8       $ 61.3       $ 74.5       $ 19.0       $ 55.5   

 

Amortization expense related to acquired intangible assets was $1.9 million and $3.8 million for the three and six months ended January 31, 2014, respectively. Amortization expense related to acquired intangible assets was $0.8 million and $1.5 million for the three and six months ended January 31, 2013, respectively.

The estimated future amortization expense related to intangible assets for each of the five succeeding fiscal years is expected to be as follows:

 

(in millions)    Estimated
future
amortization
expense
 

2014 (remaining six months)

   $ 3.8   

2015

     7.6   

2016

     6.6   

2017

     5.9   

2018

     5.0   
  

 

 

 
   $ 28.9   
  

 

 

 

We performed the annual impairment test for our goodwill and other intangible assets with indefinite lives as of December 31, 2013. Goodwill represents the purchase price in excess of the net amount assigned to assets acquired and liabilities assumed by us in connection with historical acquisitions. The goodwill as of December 31, 2013 relates to our acquisitions of Copley Controls in April 2008, Ultrasonix in March 2013, and PocketSonics in September 2013. In accordance with U.S. GAAP, we elected to bypass the qualitative assessment and proceeded to step one of the impairment test by comparing the fair value of the reporting units to their carrying values. A reporting unit, for the purpose of the impairment test, is at or below the operating segment level, and constitutes a business for which discrete financial information is available and regularly reviewed by segment management. The goodwill from the acquisition of Copley Controls, of $1.8 million, is included in our OEM reporting unit under the Medical Imaging segment. For purposes of assessing our annual impairment, the goodwill from the acquisitions of Ultrasonix and PocketSonics, of $55.2 million, are included in our Ultrasound reporting unit. Our impairment assessment considered both the market approach and income approach with different probabilities assigned to each. Under the market approach, the fair value of the reporting unit is based on trading multiples and a control premium, which was determined based on an analysis of control premiums for recent relevant acquisitions. Under the income approach, the fair value of the reporting unit is based on the present value of estimated future cash flows. The income approach is dependent on a number of significant management assumptions including estimates of future sales, future gross margin percentage, and discount rates. We determined that the fair values of the OEM and Ultrasound reporting units were in excess of their carrying values, and therefore it was not necessary for us to perform step two of the impairment test.

We compared the fair value of the Copley tradename using the relief from royalty approach to its carrying value as of December 31, 2013. The relief from royalty approach utilized an after-tax royalty rate and a discount rate. The after-tax royalty rate was determined based on royalty research and margin analysis while the discount rate was determined after consideration of market rates of return on debt and equity capital, the weighted average return on invested capital and the risk associated with achieving forecasted sales for the Copley tradename. We determined that the fair value of the Copley tradename was in excess of its carrying value.

Our IPR&D asset arises from our acquisition of PocketSonics. We compared the fair value of the IPR&D using the income approach to its carrying value at December 31, 2013 and determined there was no impairment. We determined the fair value of the IPR&D using a probability-adjusted cash flow model. We expect to begin amortizing the IPR&D over the product life cycle once production of the product begins, which is expected to be within the next six to fifteen months. We expect to utilize this IPR&D asset in our Ultrasound segment.